TD Cowen Maintains Buy on Zymeworks, Raises Price Target to $39
Benzinga Newsdesk 2 hours ago
Analyst RatingsNewsPrice Target
TD Cowen analyst Yaron Werber maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $34 to $39.
TD Cowen analyst Yaron Werber maintains Zymeworks (NASDAQ:ZYME) with a Buy and raises the price target from $34 to $39.